Revitalist Lifestyle and Wellness CEO Kathryn A. Walker to Speak at The AANA Annual Congress on Psychedelics in Anesthesia

Vancouver, British Columbia–(Newsfile Corp. – July 31, 2024) – Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) (the “Company”) announces that Kathryn A. Walker, CEO of Revitalist Lifestyle and Wellness Ltd., will be presenting at the American Association of Nurse Anesthesiologists (AANA) Annual Congress. The event will take place from August 2-6, 2024, at the San Diego Convention Center.

Walker’s session, “Entering the World of Psychedelics as an Anesthesia Professional,” is scheduled for August 5, 2024, from 3:30 PM to 4:30 PM PT in Hall B on the Lower Level.

In this session, Walker will delve into the emerging field of psychedelic medicines and their relevance to nurse anesthetists. With psychedelic therapies rapidly advancing in both medical and mental health contexts, Walker will discuss how these medications can enhance anesthesia practices, including medication delivery techniques and therapeutic communication styles.

The session will cover the following learning objectives:

• Identification of psychedelic medicines and their legal approval dates at both federal and state levels.
• Understanding the pharmacologic nature of psychedelic medications and their applications in mental health, pain syndromes, and neurodegenerative diseases.
• General concepts for working in the outpatient community and the requirements for meeting state and federal guidelines as a practitioner.

“Psychotropic medications are becoming a transformative element in healthcare, offering new opportunities for improving mental health and managing complex conditions,” said Kathryn A. Walker. “Nurse anesthetists are uniquely equipped to lead in this evolving field, and our session will provide valuable insights into how CRNAs can leverage their expertise to contribute to this exciting area.”

Attendees can earn Class A credit by participating in the live session in-person or via live webinar. Please note that recorded sessions will not be available immediately following the Congress due to CE guidelines.

For more information and to register for the event, please visit AANA Annual Congress or access the presentation details directly at AANA 2024 Presentation.

About Revitalist Lifestyle and Wellness Ltd. Revitalist (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) is a mental health and wellness company focused on comprehensive care in the ketamine wellness space offering innovative, evidenced based services. The Company operates through physical locations and virtual offices across the United States and the British Virgin Islands.

Founded and led by Kathryn Walker, an advanced provider in the psychedelic space, Revitalist is at the forefront of this emerging field. Visit Revitalist.com for more information.

Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to known and unknown risks, uncertainties and assumptions and accordingly, actual results and future events could differ materially from those expressed or implied in such statements. You are hence cautioned not to place undue reliance on forward-looking statements. All statements other than statements of present or historical fact are forward-looking statements, including statements with respect to Revitalist™’ future business plans and partnerships. Forward-looking statements include words or expressions such as “proposed”, “anticipated”, “will”, “subject to”, “near future”, “in the event”, “would”, “expect”, “prepared to” and other similar words or expressions and include, but are not limited to: the ability of Revitalist™ to secure patent protection; the regulatory environment in which Revitalist™ operates; the ability of Revitalist™ to carry out its business plans and unforeseen challenges in carrying out such plans; trends in the future use of psychedelics; general business, economic, competitive, political and social uncertainties; the state of capital markets; and other unforeseen events, developments, or factors causing any of the aforesaid expectations, assumptions, and other factors ultimately being inaccurate or irrelevant. The forward-looking information contained in this news release is expressly qualified by this cautionary statement. We disclaim any obligation to update or revise these forward-looking statements, except as required by applicable law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/218288